MAIA Biotechnology Inc (MAIA)
2.13
-0.25
(-10.50%)
USD |
NYAM |
Jan 08, 16:00
2.10
-0.03
(-1.41%)
After-Hours: 20:00
MAIA Biotechnology SG&A Expense (Quarterly): 1.521M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 76.60M |
| Regeneron Pharmaceuticals Inc | 714.40M |
| Aspira Womens Health Inc | 4.191M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |